| Chimeric antigen receptor–modified T cells in chronic lymphoid leukemia DL Porter, BL Levine, M Kalos, A Bagg, CH June New England Journal of Medicine 365 (8), 725-733, 2011 | 4509 | 2011 |
| T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia M Kalos, BL Levine, DL Porter, S Katz, SA Grupp, A Bagg, CH June Science translational medicine 3 (95), 95ra73-95ra73, 2011 | 3184 | 2011 |
| Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer SE Raper, N Chirmule, FS Lee, NA Wivel, A Bagg, G Gao, JM Wilson, ... Molecular genetics and metabolism 80 (1-2), 148-158, 2003 | 1901 | 2003 |
| Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia DL Porter, WT Hwang, NV Frey, SF Lacey, PA Shaw, AW Loren, A Bagg, ... Science translational medicine 7 (303), 303ra139-303ra139, 2015 | 1855 | 2015 |
| International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data DA Arber, A Orazi, RP Hasserjian, MJ Borowitz, KR Calvo, HM Kvasnicka, ... Blood, The Journal of the American Society of Hematology 140 (11), 1200-1228, 2022 | 1252 | 2022 |
| Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma GP Linette, EA Stadtmauer, MV Maus, AP Rapoport, BL Levine, L Emery, ... Blood, The Journal of the American Society of Hematology 122 (6), 863-871, 2013 | 1234 | 2013 |
| Chimeric antigen receptor T cells against CD19 for multiple myeloma AL Garfall, MV Maus, WT Hwang, SF Lacey, YD Mahnke, JJ Melenhorst, ... New England Journal of Medicine 373 (11), 1040-1047, 2015 | 649 | 2015 |
| Survival of acute myeloid leukemia cells requires PI3 kinase activation Q Xu, SE Simpson, TJ Scialla, A Bagg, M Carroll Blood 102 (3), 972-980, 2003 | 620 | 2003 |
| Utility of FDG-PET scanning in lymphoma by WHO classification R Elstrom, L Guan, G Baker, K Nakhoda, JA Vergilio, H Zhuang, S Pitsilos, ... Blood, The Journal of the American Society of Hematology 101 (10), 3875-3876, 2003 | 583 | 2003 |
| International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman disease DC Fajgenbaum, TS Uldrick, A Bagg, D Frank, D Wu, G Srkalovic, ... Blood, The Journal of the American Society of Hematology 129 (12), 1646-1657, 2017 | 512 | 2017 |
| Genetic inactivation of CD33 in hematopoietic stem cells to enable CAR T cell immunotherapy for acute myeloid leukemia MY Kim, KR Yu, SS Kenderian, M Ruella, S Chen, TH Shin, AA Aljanahi, ... Cell 173 (6), 1439-1453. e19, 2018 | 410 | 2018 |
| Bone marrow fibrosis: pathophysiology and clinical significance of increased bone marrow stromal fibres DJ Kuter, B Bain, G Mufti, A Bagg, RP Hasserjian British journal of haematology 139 (3), 351-362, 2007 | 328 | 2007 |
| Persistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T-cell therapy VG Bhoj, D Arhontoulis, G Wertheim, J Capobianchi, CA Callahan, ... Blood, The Journal of the American Society of Hematology 128 (3), 360-370, 2016 | 233 | 2016 |
| Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms SA Wang, RP Hasserjian, PS Fox, HJ Rogers, JT Geyer, ... Blood, The Journal of the American Society of Hematology 123 (17), 2645-2651, 2014 | 220 | 2014 |
| Erythropoietin gene therapy leads to autoimmune anemia in macaques G Gao, C Lebherz, DJ Weiner, R Grant, R Calcedo, B McCullough, ... Blood 103 (9), 3300-3302, 2004 | 202 | 2004 |
| In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior A Carvajal-Cuenca, LF Sua, NM Silva, S Pittaluga, C Royo, JY Song, ... Haematologica 97 (2), 270, 2012 | 195 | 2012 |
| Single-cell analysis of Hodgkin and Reed-Sternberg cells: molecular heterogeneity of gene expression and p53 mutations LH Trumper, G Brady, A Bagg, D Gray, SL Loke, H Griesser, R Wagman, ... | 195 | 1993 |
| Guidance for fluorescence in situ hybridization testing in hematologic disorders DJ Wolff, A Bagg, LD Cooley, GW Dewald, BA Hirsch, PB Jacky, KW Rao, ... The Journal of molecular diagnostics 9 (2), 134-143, 2007 | 177 | 2007 |
| A robust xenotransplantation model for acute myeloid leukemia PV Sanchez, RL Perry, JE Sarry, AE Perl, K Murphy, CR Swider, A Bagg, ... Leukemia 23 (11), 2109-2117, 2009 | 171 | 2009 |
| The impact of EBV status on characteristics and outcomes of posttransplantation lymphoproliferative disorder MR Luskin, DS Heil, KS Tan, S Choi, EA Stadtmauer, SJ Schuster, ... American Journal of Transplantation 15 (10), 2665-2673, 2015 | 166 | 2015 |
